News
VANCOUVER, BC / / April 10, 2025 / Onco-Innovations Limited (CSE:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that its subsidiary, Inka Health Corp.
Portland, Oregon & Vancouver, B.C., April 10, 2025 (GLOBE NEWSWIRE) -- Molecular You, a leading molecular medicine platform ...
Signios Biosciences ("Signios Bio"), a science-first biotechnology company at the forefront of multiomics and AI-powered ...
The installation of next-generation proteomics and multi-omics technology at the Baker Institute this month will provide ...
Nautilus Biotechnology, Inc.’s NAUT share price has dipped by 10.19%, which has investors questioning if this is right time ...
Explore how proteomics, AI and microsampling are advancing biomarker discovery. Learn how these innovations are shaping the ...
Distinguished, highly accomplished clinician with stellar track record of successfully leading numerous registrational trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results